• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMartin Shkreli

Martin Shkreli

Page 4 of 8
Mylan NV Chief Executive Officer Heather Bresch Interview
FinanceMylan CEO Blamed Obamacare for EpiPen Sticker Shock
By Jen WiecznerAugust 24, 2016
Democratic Presidential Nominee Hillary Clinton Delivers Speech On The Economy
HealthPharma Bro Martin Shkreli Takes On Hillary Clinton Over Mylan’s EpiPen
By Sy MukherjeeAugust 24, 2016
Annual Allen And Co. Investors Meeting Draws CEO's And Business Leaders To Sun Valley, Idaho
TechA Definitive List of Recently ‘Hacked’ CEOs and Celebrities
By Robert HackettJuly 27, 2016
House Oversight Hearing On Prescription Drug Price Increases
LeadershipThe ‘Most Hated Man on the Internet’ Hates Brunch
By Maxine Builder and Extra CrispyJuly 25, 2016
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
TechMartin Shkreli is Getting Into Magic: the Gathering, and Gamers Are Conflicted
By David Z. MorrisJuly 10, 2016
Martin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices
HealthMartin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices
By Sy MukherjeeJuly 1, 2016
Former Pharmaceutical CEO Martin Shkreli Appears In Court Over Multiple Fraud Charges
LeadershipHere’s What ‘The Most Hated Man in America’ Thinks About Donald Trump
By Lucinda ShenJune 3, 2016
Fortune Global Forum 2015
LeadershipMeet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals
By Bill GeorgeMay 10, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
FinanceBiotech Stocks Are Down 25% So Far This Year
By Sy MukherjeeMay 6, 2016
Former Pharmaceutical CEO Martin Shkreli Appears In Court Over Multiple Fraud Charges
FinanceMartin Shkreli Could Be Facing Even More Charges
By Daniel BentleyMay 3, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant’s CEO Will Have to Testify at a U.S. Congressional Hearing
By ReutersMarch 28, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthMartin Shkreli’s Former Colleague: We Advised Him Against That Infamous Price Hike
By Sy MukherjeeMarch 17, 2016
MSMB Capital Management CIO Martin Shkreli
FinanceEven Pharma Bro Martin Shkreli Wouldn’t Touch Valeant
By Lucinda ShenMarch 15, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
FinanceThis Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up
By Jen WiecznerMarch 4, 2016
UNITED STATES - FEBRUARY 04: Martin Shkreli, former CEO Turing Pharmaceuticals, invoked his Fifth Amendment right against self-incrimination during a House Oversight and Government Reform Committee in Rayburn Building on "methods and reasoning behind recent drug price increases," February 04, 2016. Turing had raised the price of Daraprim, used by AIDS and cancer patients, from $13.50 to $750 a pill. (Photo By Tom Williams/CQ Roll Call)
LeadershipSeveral Witnesses in the Martin Shkreli Case Are Worried About Retaliation
By ReutersFebruary 19, 2016
1
  • 2
  • 3
  • 4
  • 5
  • 6
...8
Most Popular
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strainplaceholder alt text
By Fortune EditorsMarch 31, 2026
Economy
Jerome Powell says the $39 trillion national debt is ‘not unsustainable,’ but warns the trajectory ‘will not end well’placeholder alt text
By Fortune EditorsMarch 30, 2026
Personal Finance
Current price of gold as of April 1, 2026placeholder alt text
By Fortune EditorsApril 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.